Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Juni 2024

Genmab — Juni 2024

Planlagt Fastgjort Låst Flyttet Genmab
946 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • SolsenS Offline
    SolsenS Offline
    Solsen
    wrote on sidst redigeret af
    #193

    Så får Genmab lov til at betale deres andel frem til marts 2029 for salg i Europa. Men vi vel forvente at US andelen bliver billigere fra i år.

    1 Reply Last reply
    0
    • SolsenS Offline
      SolsenS Offline
      Solsen
      wrote on sidst redigeret af
      #194

      Undkyld US patentet udløber i 2027

      1 Reply Last reply
      0
      • P Offline
        P Offline
        peter12
        wrote on sidst redigeret af
        #195

        Det undrer mig at de bare kan forlænge ?

        1 Reply Last reply
        0
        • SolsenS Offline
          SolsenS Offline
          Solsen
          wrote on sidst redigeret af
          #196

          0,25 % ned fra ecb

          1 Reply Last reply
          0
          • SolsenS Offline
            SolsenS Offline
            Solsen
            wrote on sidst redigeret af
            #197

            Lad det være begyndelse på en rentenedtur, som vi aktionærer vil kunne få glæde af.

            1 Reply Last reply
            0
            • J Offline
              J Offline
              JKY_VH
              wrote on sidst redigeret af
              #198

              enig Solsen

              1 Reply Last reply
              0
              • SolsenS Offline
                SolsenS Offline
                Solsen
                wrote on sidst redigeret af
                #199

                HALO hæver guidance med $80 mln for 2024. Kan ikke lige gennemskue tallene. Men muligt at JNJ og Genmab skal dele den udgift. https://finance.yahoo.com/news/halozyme-raises-full-2024-financial-123000685.html

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #200

                  i can't say that i understand what happens here to be honest, how they can have adjusted the patent on an existing product..

                  1 Reply Last reply
                  0
                  • SolsenS Offline
                    SolsenS Offline
                    Solsen
                    wrote on sidst redigeret af
                    #201

                    Yes quite strange.

                    1 Reply Last reply
                    0
                    • SolsenS Offline
                      SolsenS Offline
                      Solsen
                      wrote on sidst redigeret af
                      #202

                      Link Preview Image
                      Celebrating 25 Years of Genmab! Today, we celebrated Genmab's 25th anniversary at their headquarters in Valby. Genmab’s CEO, Jan van de Winkel, opened the market together with employees, marking a… | Peter Legind-Hansen

                      Celebrating 25 Years of Genmab! Today, we celebrated Genmab's 25th anniversary at their headquarters in Valby. Genmab’s CEO, Jan van de Winkel, opened the market together with employees, marking a memorable moment for the company. We are proud to have Genmab among the strong listed companies on Nasdaq Copenhagen, contributing to Denmark's growth, innovation, and job creation. Nasdaq Copenhagen will continue to follow Genmab's success and innovation in the years to come🚀 Jan van de Winkel, Ph.D., Birgitte Stephensen, Marisol Mendez Peron, Solrun Sigfusdottir Øfjord, Carsten Borring, Sara Nolkrantz

                      favicon

                      LinkedIn (www.linkedin.com)

                      1 Reply Last reply
                      0
                      • Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktør
                        wrote on sidst redigeret af
                        #203

                        Godmorgen 🙂

                        1 Reply Last reply
                        0
                        • S Offline
                          S Offline
                          Stroka
                          wrote on sidst redigeret af
                          #204

                          God morgen 🙂

                          1 Reply Last reply
                          0
                          • B Offline
                            B Offline
                            bibob
                            wrote on sidst redigeret af
                            #205

                            God morgen. 🙂

                            1 Reply Last reply
                            0
                            • L Offline
                              L Offline
                              lahn1
                              wrote on sidst redigeret af
                              #206

                              Kom så med en god gammeldavs fredags nyhed, tak!

                              1 Reply Last reply
                              0
                              • concilladoC Offline
                                concilladoC Offline
                                concillado
                                wrote on sidst redigeret af
                                #207

                                @E L: ..smells like a new court case! xD

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #208

                                  noooooo...! 😄

                                  1 Reply Last reply
                                  0
                                  • BulderB Offline
                                    BulderB Offline
                                    Bulder
                                    wrote on sidst redigeret af
                                    #209

                                    ?

                                    1 Reply Last reply
                                    0
                                    • BulderB Offline
                                      BulderB Offline
                                      Bulder
                                      wrote on sidst redigeret af
                                      #210

                                      Sorry

                                      1 Reply Last reply
                                      0
                                      • L Offline
                                        L Offline
                                        lahn1
                                        wrote on sidst redigeret af
                                        #211

                                        I read it as it a patent on the production method ? Havent read the patent itself though

                                        1 Reply Last reply
                                        0
                                        • SolsenS Offline
                                          SolsenS Offline
                                          Solsen
                                          wrote on sidst redigeret af
                                          #212

                                          De er dygtige til at beskytte deres patenter. Det er et selvstændigt område i enhver Parma- og biotechvirksomhed der kræver opmærsomhed og ressourcer. Vi kan føle hvad der har kostet Genmab. Men HALOs træk kan de ikke bebrejdes.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper